Reports >
Life Sciences
>
Biobanks Market Report
Biobanks Market Report
First published: 21 October 2024 | Last updated: 22 April 2026 | Report Code: biobanks
Biobanks Market — USD 12.5 billion in 2023, Growing to USD 25.80B by 2033 at 7.3% CAGR
This report provides an in-depth analysis of the Biobanks market from 2023 to 2033, including market size, growth potential, regional insights, and trends that are shaping the industry. It aims to equip stakeholders with valuable data for strategic planning.
Key Takeaways
- Global market value rises from $12.50 Billion in 2023 to $25.80 Billion in 2033 at a 7.3% CAGR.
- North America leads in both size and growth, expanding from $4.28 Billion to $8.84 Billion over the forecast.
- Europe and Asia Pacific show meaningful expansion: Europe $3.39 Billion to $7.01 Billion; Asia Pacific $2.45 Billion to $5.06 Billion.
- Core offerings span human, animal, and microbial samples and include sample collection, storage, and data management functions.
- Key market participants include Thermo Fisher Scientific, Qiagen, Bristol Myers Squibb, Luminex Corporation, and Medpace.
Biobanks Market Report — Executive Summary
The global biobanks sector is valued at $12.50 Billion in 2023 and is forecast to reach $25.80 Billion by 2033, reflecting a 7.3% CAGR from 2023 to 2033. Market momentum stems from mounting requirements for curated biological specimens, growing investment by healthcare and research institutions, and enhancements in storage and data capabilities. North America stands as both the largest and the swiftest-expanding market, supporting significant commercial and research biobank activity. The industry structure encompasses population, commercial, and research biobanks, multiple sample types including human, animal, and microbial specimens, and core functions such as sample collection, storage, and data management. Industry participants — including Thermo Fisher Scientific, Qiagen, Bristol Myers Squibb, Luminex Corporation, and Medpace — are active across service provision and technology adoption. Key trends addressed in the report include operational standardization, investments in infrastructure, and the scaling of data management platforms. The study provides segment-level assessment, regional breakdowns, and a competitive view to guide stakeholders in strategic planning and investment decisions.
Key Growth Drivers
- Rising demand for curated biological samples from research and clinical applications drives collection and storage needs.
- Increased funding and investments by healthcare and research organizations accelerate biobank establishment and expansion.
- Advances in sample preservation and storage technologies improve long-term specimen integrity and operational efficiency.
- Growing emphasis on standardized data management and digital platforms enhances sample traceability and research usability.
- Expansion of commercial biobanks and partnerships with pharmaceutical and diagnostics firms broadens service offerings.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $12.50 Billion |
| CAGR (2023-2033) | 7.3% |
| 2033 Market Size | $25.80 Billion |
| Top Companies | Thermo Fisher Scientific, Qiagen , Bristol Myers Squibb, Luminex Corporation, Medpace |
| Published Date | 21 October 2024 |
| Last Modified Date | 22 April 2026 |
Biobanks Market Overview
Customize Biobanks Market Report market research report
- ✔ Get in-depth analysis of Biobanks market size, growth, and forecasts.
- ✔ Understand Biobanks's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biobanks
What is the Market Size & CAGR of Biobanks Market Report market in 2023?
Biobanks Industry Analysis
Biobanks Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biobanks Market Report Market Analysis Report by Region
Europe Biobanks Market Report:
Europe grows from $3.39 Billion in 2023 to $7.01 Billion by 2033. Expansion is supported by expanding biomedical research and adoption of standardized sample storage and data practices, positioning the region as a major contributor to sustained overall market growth.Asia Pacific Biobanks Market Report:
Asia Pacific progresses from $2.45 Billion in 2023 to $5.06 Billion in 2033. Growing research activities and increasing biobanking initiatives across academic and clinical institutions support market expansion over the forecast period, driving investments in sample storage and data management capabilities.North America Biobanks Market Report:
North America expands from $4.28 Billion in 2023 to $8.84 Billion in 2033. As both the largest and fastest-growing market, regional strength reflects concentrated research funding, advanced biobanking infrastructure, and significant participation by leading firms such as Thermo Fisher Scientific and Qiagen.South America Biobanks Market Report:
Middle East & Africa Biobanks Market Report:
Middle East and Africa moves from $1.22 Billion in 2023 to $2.51 Billion by 2033. Regional expansion is supported by growing healthcare research initiatives and development of local biobanking capacity, leading to increased attention on storage and data management improvements.Tell us your focus area and get a customized research report.
Research Methodology
Biobanks Market Analysis By Type
The Biobanks market is primarily segmented into three major types: Population Biobanks, Commercial Biobanks, and Research Biobanks. Population Biobanks account for a significant market share, driven by their crucial role in epidemiological studies and public health research. In 2023, Population Biobanks are valued at $8.51 billion and are expected to grow to $17.57 billion by 2033. Commercial Biobanks represent around $2.94 billion in 2023, likely reaching $6.06 billion by 2033, facilitating drug discovery and development. Research Biobanks, while smaller in size at $1.05 billion in 2023, are projected to grow to $2.17 billion by 2033, supporting academic and research organization needs.
Biobanks Market Analysis By Sample Type
Segments include Human Samples, Animal Samples, and Microbial Samples. Human Samples dominate the market, valued at $8.51 billion in 2023, expected to reach $17.57 billion by 2033. Animal Samples are projected to grow from $2.94 billion to $6.06 billion, while Microbial Samples, valued at $1.05 billion, aim to hit $2.17 billion, indicating a diverse landscape for biobanks catering to varied research needs.
Biobanks Market Analysis By End User
The Biobanks market also segments based on end-users, including Research Organizations, Pharmaceutical Companies, and Diagnostics Companies. Research Organizations are the largest segment, valued at $8.51 billion in 2023, projected to surge to $17.57 billion by 2033. Pharmaceutical Companies are expected to increase from $2.94 billion to $6.06 billion, while Diagnostics Companies grow from $1.05 billion to $2.17 billion, reflecting increasing reliance on biobanks for innovation and product development.
Biobanks Market Analysis By Functionality
Functional segments in the Biobanks market encompass Sample Collection, Sample Storage, and Data Management. Sample Collection accounts for a significant share at $8.51 billion in 2023, anticipated to rise to $17.57 billion by 2033, central for biobank operations. Sample Storage, with market values of $2.94 billion and projections to $6.06 billion, plays a critical role in ensuring sample integrity. Data Management is also essential, projected to grow from $1.05 billion to $2.17 billion, highlighting the importance of effective data handling in biobanking.
Biobanks Market Analysis By Region
Regional analysis reveals differing dynamics across markets. North America leads with significant investments and a strong framework for biobanks, while Europe follows closely, emphasizing research collaboration. Asia-Pacific is witnessing rapid growth driven by increasing healthcare demands. South America and Middle East & Africa are emerging markets, showing promising growth due to global partnerships fostering biobank establishment.
Biobanks Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biobanks Industry
Thermo Fisher Scientific:
A leading company providing a wide range of products and services that support biobanking, including sample storage, data management solutions, and innovative equipment.Qiagen :
A prominent player in the biotech sector, Qiagen specializes in sample preparation and diagnostics, which are critical for biobanking applications.Bristol Myers Squibb:
A global biopharmaceutical company that extensively utilizes biobanks in its R&D processes to enhance drug development and personalized medicine.Luminex Corporation:
Known for its multiplexing technology that enables efficient biobanking practices, Luminex provides solutions that streamline sample analysis.Medpace:
A clinical contract research organization that partners with biobanks to facilitate drug development and clinical trials with a focus on regulatory compliance.We're grateful to work with incredible clients.
FAQs
What is the market size of Biobanks Market Report in 2023?
$12.50 Billion in 2023, expanding to $25.80 Billion by 2033. The market is projected to grow at a CAGR of 7.3% over the 2023 to 2033 forecast period.
How big is the North America market in 2023?
$4.28 Billion in 2023, with a projection to $8.84 Billion by 2033. North America is both the largest and fastest-growing region in the forecast period.
Why is the market growing?
Growth is propelled by increasing demand for biological samples for research and diagnostics, expanding biopharmaceutical investment, and improvements in sample collection, storage, and data management capabilities across organizations.
Which regions show the highest growth between 2023 and 2033?
North America shows the strongest expansion and is both the largest and fastest-growing region. Europe and Asia Pacific also register substantial increases in market value between 2023 and 2033.
Who are the leading companies in the market?
Top firms include Thermo Fisher Scientific, Qiagen, Bristol Myers Squibb, Luminex Corporation, and Medpace, active across sample services, storage operations, and data management offerings within the market.
What is CAGR of the market over the forecast period?
The compound annual growth rate (CAGR) for the forecast period 2023 to 2033 is 7.3%, reflecting steady expansion from $12.50 Billion in 2023 to $25.80 Billion in 2033.
What are the primary segments covered?
Primary segments include by-type (Population, Commercial, Research biobanks), by-region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), by-end-user, sample-type, and functionality such as storage and data management.
How big is Europe market in 2023?
$3.39 Billion in 2023, increasing to $7.01 Billion by 2033. Europe demonstrates meaningful growth over the forecast period, supported by expanding research activities and demand for biobanking services.